These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1382356)

  • 1. [Development of resistance of herpes simplex virus to antivirus drugs in vitro].
    Chen ZJ; Liu WG; Song JZ
    Yao Xue Xue Bao; 1992; 27(1):10-4. PubMed ID: 1382356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus.
    Saijo M; Yasuda Y; Yabe H; Kato S; Suzutani T; De Clercq E; Niikura M; Maeda A; Kurane I; Morikawa S
    J Med Virol; 2002 Sep; 68(1):99-104. PubMed ID: 12210436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acyclovir-resistant herpes simplex virus infections in immunocompromised patients].
    Jansen CL; Maris-Tegeler WG; Wertheim-van Dillen PM; Frissen PH; Weiland HT; van der Noordaa J
    Ned Tijdschr Geneeskd; 1992 Feb; 136(6):280-4. PubMed ID: 1311058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential switching of DNA polymerase and thymidine kinase-mediated HSV-1 drug resistance in an immunocompromised child.
    Stránská R; van Loon AM; Bredius RG; Polman M; Nienhuis E; Beersma MF; Lankester AC; Schuurman R
    Antivir Ther; 2004 Feb; 9(1):97-104. PubMed ID: 15040541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survey of acyclovir-resistant herpes simplex virus in the Netherlands: prevalence and characterization.
    Stránská R; Schuurman R; Nienhuis E; Goedegebuure IW; Polman M; Weel JF; Wertheim-Van Dillen PM; Berkhout RJ; van Loon AM
    J Clin Virol; 2005 Jan; 32(1):7-18. PubMed ID: 15572000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting herpes simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA.
    Chen H; Teng L; Li JN; Park R; Mold DE; Gnabre J; Hwu JR; Tseng WN; Huang RC
    J Med Chem; 1998 Jul; 41(16):3001-7. PubMed ID: 9685239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antiviral sensitivity of herpes simplex virus in immunocompromised patients].
    Illán H; Jacob N; Maiolo E; Cisterna D; Schiavelli R; Freire MC
    Rev Argent Microbiol; 2004; 36(2):88-91. PubMed ID: 15470869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro antiviral activity of distamycin A against clinical isolates of herpes simplex virus 1 and 2 from transplanted patients.
    Matteoli B; Bernardini S; Iuliano R; Parenti S; Freer G; Broccolo F; Baggiani A; Subissi A; Arcamone F; Ceccherini-Nelli L
    Intervirology; 2008; 51(3):166-72. PubMed ID: 18663321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of acyclovir-resistant herpes simplex viruses isolated from the general immunocompetent population and patients with acquired immunodeficiency syndrome.
    Ziyaeyan M; Alborzi A; Japoni A; Kadivar M; Davarpanah MA; Pourabbas B; Abassian A
    Int J Dermatol; 2007 Dec; 46(12):1263-6. PubMed ID: 18173520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered sensitivity to antiviral drugs of herpes simplex virus isolates from a patient with the acquired immunodeficiency syndrome.
    Birch CJ; Tachedjian G; Doherty RR; Hayes K; Gust ID
    J Infect Dis; 1990 Sep; 162(3):731-4. PubMed ID: 2167340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility to acyclovir of herpes simplex virus isolates obtained between 1977 and 1996 in Japan.
    Hasegawa T; Kawana T; Okuda T; Horii M; Tsukada T; Shiraki K
    J Med Virol; 2001 Jan; 63(1):57-63. PubMed ID: 11130888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of generation and replication of acyclovir-resistant herpes simplex virus by a sensitive virus.
    Okuda T; Kurokawa M; Matsuo K; Honda M; Niimura M; Shiraki K
    J Med Virol; 2004 Jan; 72(1):112-20. PubMed ID: 14635018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different in vitro effects of dual combinations of anti-herpes simplex virus compounds.
    Schinazi RF; Nahmias AJ
    Am J Med; 1982 Jul; 73(1A):40-8. PubMed ID: 6285731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid determination of antiviral drug susceptibility of herpes simplex virus types 1 and 2 by real-time PCR.
    Thi TN; Deback C; Malet I; Bonnafous P; Ait-Arkoub Z; Agut H
    Antiviral Res; 2006 Mar; 69(3):152-7. PubMed ID: 16388859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiplicity dependence and sensitivity of herpes simplex virus isolates to antiviral compounds.
    Harmenberg J; Wahren B; Sundqvist VA; Levén B
    J Antimicrob Chemother; 1985 May; 15(5):567-73. PubMed ID: 2989239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiherpetic properties of acyclovir 5'-hydrogenphosphonate and the mutation analysis of herpes virus resistant strains.
    Gus'kova AA; Skoblov MY; Korovina AN; Yasko MV; Karpenko IL; Kukhanova MK; Andronova VL; Galegov GA; Skoblov YS
    Chem Biol Drug Des; 2009 Oct; 74(4):382-9. PubMed ID: 19691467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity of HSV clinical isolates to foscarnet and in vitro dual combination of foscarnet and acyclovir.
    Al-Samarai A; Kinghorn G; Potter C
    Chemioterapia; 1987 Jun; 6(2 Suppl):665-6. PubMed ID: 2855616
    [No Abstract]   [Full Text] [Related]  

  • 18. [Resistance of herpes simplex viruses to antiviral drugs].
    Scieux C; Bianchi A
    Pathol Biol (Paris); 1993 Feb; 41(2):172-7. PubMed ID: 8392160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The sensitivity of acyclovir-resistant mutants of herpes simplex virus to other antiviral drugs.
    Field H; McMillan A; Darby G
    J Infect Dis; 1981 Feb; 143(2):281-5. PubMed ID: 6260876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes simplex virus variants restraint to high concentrations of acyclovir exist in clinical isolates.
    Parris DS; Harrington JE
    Antimicrob Agents Chemother; 1982 Jul; 22(1):71-7. PubMed ID: 6289742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.